Workflow
Allan's Landscaping & Disposal Services Wins 2025 Consumer Choice Award for Landscape Contracting and Waste Management in Saskatoon
Accessnewswire· 2025-09-11 20:00
Saskatoon's trusted choice for quality landscaping and eco-friendly waste solutions for over four decades. SASKATOON, SK / ACCESS Newswire / September 11, 2025 / Allan's Landscaping & Disposal Services, a cornerstone of Saskatoon's landscaping and waste management industry, has won the 2025 Consumer Choice Award in the Landscape Contractor / Waste Management category. ...
Kroger Reports Second Quarter 2025 Results andUpdates Guidance for 2025
Prnewswire· 2025-09-11 20:00
Accessibility StatementSkip Navigation Second Quarter Highlights CINCINNATI, Sept. 11, 2025 /PRNewswire/ -- The Kroger Co. (NYSE: KR) today reported its second quarter 2025 results, updated guidance and shared progress on key priorities. Comments from Chairman and CEO Ron Sargent "Kroger delivered another quarter of strong results, which demonstrates the clear and measurable progress we've made on our priorities – to simplify our organization, to improve the customer experience and to focus on work that cre ...
ZenaTech Announces the Acquisition of Lescure Engineers Inc. Expanding Drone as a Service (DaaS) to California’s Precision Agriculture and Viticulture Markets
Globenewswire· 2025-09-11 20:00
VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions announces acquisition of Lescure Engineers Inc., an established Santa Rosa, California-based civil engineering and land surveying firm. The acquisition will close by September 12th and will mark ZenaTech’s first ...
AAON To Present at D.A. Davidson's Diversified Industrials & Services Conference on September 18, 2025
Prnewswire· 2025-09-11 20:00
Accessibility StatementSkip Navigation Management is scheduled to participate in a 40-minute fireside chat with D.A. Davidson analyst Brent Thielman at 11:30 a.m. EDT and host in-person one-on-one meetings during the event. A live webcast of the fireside chat will be available in the Investor Relations section of AAON's website at https://aaon.com/investors. Â Investors interested in arranging one-on-one meetings should contact their D.A. Davidson conference representative. About AAONFounded in 1988, AAON i ...
Kazia Therapeutics Reports Complete Ex Vivo Disruption of Large Circulating Tumor Cell Clusters in Stage IV HER2-Positive Breast Cancer with Paxalisib Monotherapy
Prnewswire· 2025-09-11 20:00
Accessibility StatementSkip Navigation SYDNEY, Sept. 11, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology- focused drug development company, today announced new findings from a collaborative research program led by Professor Sudha Rao at QIMR Berghofer. In this ex vivo study, blood samples from Stage IV HER2-positive metastatic breast cancer (mBC) patients were profiled to evaluate the effect of paxalisib, Kazia's investigational PI3K–mTOR inhibitor, on metastatic burden. Paxalisi ...
Trinity Capital Inc. Provides $26 Million in Growth Capital to Unmind to Further Empower Workplace Mental Health
Prnewswire· 2025-09-11 20:00
Accessibility StatementSkip Navigation PHOENIX, Sept. 11, 2025 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading alternative asset manager, today announced the commitment of $26 million in growth capital to Unmind, the workplace mental health platform delivering complete care in one solution, powered by AI. Unmind combines human expertise, digital innovation, and proven science so every employee can access the right support – from proactive and preventative AI guidance to ther ...
Luxxfolio Advances Litecoin Mining Strategy
Newsfile· 2025-09-11 20:00
Vancouver, British Columbia--(Newsfile Corp. - September 11, 2025) - Luxxfolio Holdings Inc. (CSE: LUXX) (OTCQB: LUXFD) (FSE: LUH0) ("Luxxfolio" or the "Company"), a leading Litecoin treasury and infrastructure company, is pleased to announce that it has advanced its Litecoin mining expansion strategy with progress on both facility planning and hardware negotiations.The Company has narrowed its shortlist of potential properties in Alberta and Saskatchewan capable of supporting large-scale mining operation ...
Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD
Globenewswire· 2025-09-11 20:00
Performance and scalability of Oracle Cloud Infrastructure AI infrastructure enables Absci to accelerate biologics design cycles and reduce costsAUSTIN, Texas and VANCOUVER, Washington, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Absci, a clinical-stage biotech company advancing novel therapeutics with generative AI, today announced a collaboration with Oracle Cloud Infrastructure (OCI) and AMD to accelerate generative AI-driven drug discovery. Absci’s generative AI Drug Creation Platform leverages OCI’s AI infrastr ...
National Drive Electric Month kicks off Sept. 12, features events in 41 states
PRWEB· 2025-09-11 20:00
"EV drivers love their cars and sharing that experience with others. The passion and enthusiasm are palpable at National Drive Electric Month events, where people can often test drive EVs to understand why EVs are so beloved" said Joel Levin, executive director of Plug In America. Post this EV growth is on an upward trajectory, and there has never been a better time to buy an EV. With more than 400 electric model trims available, there is an EV for every lifestyle. Plus, there's a robust used EV market, an ...
Kairos Pharma Announces Virtual KOL Event to Provide Perspectives on ENV105 Interim Efficacy Results in Advanced Prostate Cancer
Businesswire· 2025-09-11 20:00
LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces that it will host a premier KOL event on Thursday, Sept. 18th at 5 p.m. ET / 2 p.m. PT to discuss diverse perspectives on the Company's interim efficacy results from a Phase 2 trial of its lead candidate, ENV105, in treating advanced prostate cancer patients. Registration is required to participate in the webcast. Interest. ...